4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-23-008072
President and CEO sold 42,000 shares at an average $20.99 ($881,720)
- President and CEO acquired 42,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Sanjiv President and CEO | 2023-02-07 | Option exercise | +14,000 | $5.04 | $70,560 | 14,000 | D: show line 1 in the form |
| Patel Sanjiv President and CEO | 2023-02-07 | Sale | −14,000 | $21.45 | $300,300 | 0 | D: show line 2 in the form |
| Patel Sanjiv President and CEO | 2023-02-08 | Option exercise | +14,000 | $5.04 | $70,560 | 14,000 | D: show line 3 in the form |
| Patel Sanjiv President and CEO | 2023-02-08 | Sale | −14,000 | $20.98 | $293,720 | 0 | D: show line 4 in the form |
| Patel Sanjiv President and CEO | 2023-02-09 | Option exercise | +14,000 | $5.04 | $70,560 | 14,000 | D: show line 5 in the form |
| Patel Sanjiv President and CEO | 2023-02-09 | Sale | −14,000 | $20.55 | $287,700 | 0 | D: show line 6 in the form |
| Open-market sales · 42,000 sh · avg $20.99 · $881,720 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Patel Sanjiv President and CEO | 2023-02-07 | Option exercise · Stock Option (Right to Buy) | −14,000 | 596,779 | D: show line 7 in the form | |||||
| Patel Sanjiv President and CEO | 2023-02-08 | Option exercise · Stock Option (Right to Buy) | −14,000 | 582,779 | D: show line 8 in the form | |||||
| Patel Sanjiv President and CEO | 2023-02-09 | Option exercise · Stock Option (Right to Buy) | −14,000 | 568,779 | D: show line 9 in the form |
Loading xslF345X03/doc4.xml…